Colitis ulcerosa und Morbus Crohn – Chronisch entzündliche Darmerkrankungen

Zusammenfassung

Morbus Crohn und Colitis ulcerosa sind inzwischen relativ gut medikamentös beherrschbar. Trotzdem ist bei etwa 16% (Colitis ulcerosa) bzw. 47% (Morbus Crohn) der Patienten innerhalb von 10 Jahren nach Diagnosestellung eine Operation nötig. Priorität sollte dabei sein, die Lebensqualität zu verbessern. Da diese jeder unterschiedlich bewertet, ist die Kommunikation mit dem Patienten essenziell.

Schlüsselwörter:

Colitis ulcerosa - Morbus Crohn - Operation - Endoskopie - Stoma - MR-Sellink

• Literatur

• 1 Schreiber S, Hartmann H, Kruis W et al. Inflammatory Bowel Disease Competence Network. Bundesgesundheitsbl 2016; 59: 465-474
• 2 Wehkamp J, Götz M, Herrlinger K et al. Inflammatory Bowel Disease. Dtsch Arztebl Int 2016; 113: 72-82
• 3 Klag T, Stange EF, Wehkamp J. Labordiagnostik bei chronisch entzündlichen Darmerkrankungen, einschließlich Blut- und Stuhldiagnostik. Gastroenterologe 2014;
• 4 Stange E. Entzündliche Darmerkrankungen – Klinik, Diagnostik und Therapie. Stuttgart: Schattauer; 2015
• 5 Magro F, Langner C, Driessen A et al. European consensus on the histopathology of inflammatory bowel disease. Journal of Crohn's and Colitis 2013; 7: 827-851
• 6 Klag T, Goetz M, Stange EF, Wehkamp J. Medical Therapy of Perianal Crohn's Disease. Viszeralmedizin 2015; 31: 265-272
• 7 Frolkis AD, Dykeman J, Negron ME et al. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology 2013; 145: 996-1006
• 8 Gan SI, Beck PL. A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management. Am J Gastroenterol 2003; 98: 2363-2371
• 9 Dignass A, Preiss JC, Aust DE et al. Aktualisierte Leitlinie zur Diagnostik und Therapie der Colitis ulcerosa 2011 – Ergebnisse einer Evidenzbasierten Konsensuskonferenz. Z Gastroenterol 2011; 49: 1276-1341
• 10 Ikeuchi HM, Uchino H, Matsuoka T et al. Surgery for ulcerative colitis in 1,000 patients. Int J Colorectal Dis 2010; 25: 959-965
• 11 Harnoy Y, Desfourneaux V, Bouguen G et al. Sexuality and fertility outcomes after hand sewn versus stapled ileal pouch anal anastomosis for ulcerative colitis. J Surg Res 2016; 200: 66-72
• 12 Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med 2011; 365: 1713-1725
• 13 Kock NG. Intra-abdominal „reservoir“ in patients with permanent ileostomy. Preliminary observations on a procedure resulting in fecal „continence“ in five ileostomy patients. Dis Colon Rectum discussion 1994; 37: 285-277
• 14 Yamamoto T, Allan RN, Keighley MR. Risk factors for intra-abdominal sepsis after surgery in Crohn's disease. Dis Colon Rectum 2000; 43: 1141-1145
• 15 Aberra FN, Lewis JD, Hass D et al. Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology 2003; 125: 320-327
• 16 Kopylov U, Ben-Horin S, Zmora O et al. Anti-tumor necrosis factor and postoperative complications in Crohn's disease: systematic review and meta-analysis. Inflamm Bowel Dis 2012; 18: 2404-2413
• 17 Norgard BM, Nielsen J, Qvist N et al. Pre-operative use of anti-TNF-alpha agents and the risk of post-operative complications in patients with Crohn's disease – a nationwide cohort study. Aliment Pharmacol Ther 2013; 37: 214-224
• 18 Waterland P, Athanasiou T, Patel H. Post-operative abdominal complications in Crohn's disease in the biological era: Systematic review and meta-analysis. World J Gastrointest Surg 2016; 8: 274-283
• 19 Cleynen I, Boucher G, Jostins L et al. Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study. Lancet 2016; 387: 156-167
• 20 Lee EC, Papaioannou N. Minimal surgery for chronic obstruction in patients with extensive or universal Crohn's disease. Ann R Coll Surg Engl 1982; 64: 229-233
• 21 Das B, Snyder M. Rectovaginal Fistulae. Clin Colon Rectal Surg 2016; 29: 50-56